Patents by Inventor David Dawbarn

David Dawbarn has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Pharmaceutical composition comprising TrkAIg2 for use in the prevention and/or treatment of cancer
    Publication number: 20070105773
    Abstract: This invention relates to the treatment of cancer and is particularly, though not exclusively concerned with the treatment of pancreatic cancer. In particular the invention related to the use of TrkAIg2 in the preparation of a medicament for the treatment and/or prevention of cancer in a patient.
    Type: Application
    Filed: October 13, 2006
    Publication date: May 10, 2007
    Applicant: The University of Bristol
    Inventors: Shelly Allen, David Dawbarn
  • Therapeutic agent for NGF
    Publication number: 20070067856
    Abstract: This invention relates to the use of a domain of Trk as a therapeutic agent and for screening purposes and rational design of NGF mimetics.
    Type: Application
    Filed: September 13, 2006
    Publication date: March 22, 2007
    Applicant: University of Bristol
    Inventors: Alan George Robertson, Shelley Allen, David Dawbarn
  • Therapeutic agent for NGF
    Publication number: 20070067857
    Abstract: This invention relates to the use of a domain of Trk as a therapeutic agent and for screening purposes and rational design of NGF nimetics.
    Type: Application
    Filed: September 13, 2006
    Publication date: March 22, 2007
    Applicant: University of Bristol
    Inventors: Alan Simpson Robertson, Shelley Allen, David Dawbarn
  • Polypeptide purification method
    Publication number: 20050070690
    Abstract: This invention relates to a purification method, particularly for purifying tyrosine kinase receptor related polypeptides, and to products made by the method. The method comprises a method of producing tyrosine kinase receptor-related polypeptides, the method comprising expressing a tyrosine kinase receptor-related polypeptide in a recombinant expression system and separating expressed monomeric tyrosine kinase receptor-related polypeptide from multimeric form(s) of the expressed polypeptide in a separation step, the separation step allowing refolding of the expressed tyrosine kinase receptor-related polypeptide into a biologically active form.
    Type: Application
    Filed: September 17, 2002
    Publication date: March 31, 2005
    Inventors: David Dawbarn, Shelly Allen, Alan Robertson
  • Pharmaceutical compositon comprising trkaig2 for use inthe prevention and/or treatment of cancer
    Publication number: 20040037831
    Abstract: This invention relates to the treatment of cancer and is particularly, though not exclusively concerned with the treatment of pancreatic cancer. In particular the invention related to the use of TrkAlg2 in the preparation of a medicament for the treatment and/or prevention of cancer in a patient.
    Type: Application
    Filed: June 23, 2003
    Publication date: February 26, 2004
    Inventors: Shelley Jane Allen, David Dawbarn
  • Therapeutic agent
    Publication number: 20030097667
    Abstract: This invention relates to the use of a domain of Trk as a therapeutic agent and for screening purposes and rational design of NGF mimetics.
    Type: Application
    Filed: October 1, 2002
    Publication date: May 22, 2003
    Inventors: Alan George Simpson Robertson, Shelley Jane Allen, David Dawbarn
  • Therapeutic agent
    Publication number: 20030096753
    Abstract: This invention relates to the use of a domain of Trk as a therapeutic agent and for screening purposes and rational design of NGF mimetics.
    Type: Application
    Filed: October 1, 2002
    Publication date: May 22, 2003
    Inventors: Alan George Simpson Robertson, Shelley Jane Allen, David Dawbarn